Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | F2 | P00734 | 3/20 | 0.40 |
| ▸ | PRSS1 | P07477 | 3/20 | 0.40 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.40 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.40 |
| ▸ | HTR6 | P50406 | 2/20 | 0.39 |
| ▸ | SLC6A9 | P48067 | 2/20 | 0.39 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | CNR2 | P34972 | 1/20 | 0.38 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | SCN1A | P35498 | 2/20 | 0.37 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.37 |
| ▸ | SCN3A | Q9NY46 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6271690 | 0.84 | CA1 (0.47) | CA1CA2CA9F2PRSS1 | |
| SCHEMBL3689853 | 0.83 | CA1 (0.46) | CA1CA2CA9F2PRSS1 | |
| SCHEMBL31406930 | 0.83 | CA1 (0.46) | CA1CA2CA9F2PRSS1 | |
| SCHEMBL2199067 | 0.82 | CA1 (0.52) | CA1CA2CA9F2PRSS1 | |
| SCHEMBL8332473 | 0.81 | CA1 (0.50) | CA1CA2CA9F2PRSS1 | |
| SCHEMBL2761905 | 0.81 | CA1 (0.50) | CA1CA2CA9F2PRSS1 | |
| SCHEMBL13609012 | 0.80 | CYP1A2 (0.55) | CA2F2PRSS1PRSS2PRSS3 | |
| SCHEMBL2197579 | 0.80 | CA1 (0.49) | CA1CA2CA9F2PRSS1 | |
| SCHEMBL6115042 | 0.79 | CA1 (0.55) | CA1CA2CA9F2PRSS1 | |
| SCHEMBL29409565 | 0.79 | CA1 (0.55) | CA1CA2CA9F2PRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2297081-B1 | 1-(2-ETHYL-BUTYL)-CYCLOHEXANECARBOXYLIC ACID ESTER AS AN INTERMEDIATE IN THE PREPARATION OF PHARMACEUTICALLY ACTIVE AMIDES | HOFFMANN LA ROCHE (CH) | 2017-03-08 | — | — | EP | disclosed |
| EP-2274278-B1 | NEW PROCESS FOR THE PREPARATIION OF CYCLOHEXANECARBOXYLIC ACID DERICATIVES | HOFFMANN LA ROCHE (CH) | 2016-08-17 | — | — | EP | disclosed |
| US-20160200672-A1 | NEW PROCESS | HOFFMANN-LA ROCHE INC. | 2016-07-14 | — | — | US | disclosed |
| US-20150361034-A1 | NEW PROCESS | HOFFMANN-LA ROCHE INC. | 2015-12-17 | — | — | US | disclosed |
| EP-2616433-B1 | PROCESS FOR PREPARING A CYCLOHEXANECARBONITRILE DERIVATIVE | HOFFMANN LA ROCHE (CH) | 2015-12-09 | — | — | EP | disclosed |
| US-20140336403-A1 | PROCESS | F. HOFFMANN-LA ROCHE AG (CH) | 2014-11-13 | — | — | US | disclosed |
| EP-2274264-B1 | NEW PROCESS FOR THE PREPARATION OF CYCLOHEXANECARBOXYLIC ACID DERIVATIVES VIA THE CORRESPONDING CYCLOHEXANECARBOXAMIDE DERIVATIVE | HOFFMANN LA ROCHE (CH) | 2014-02-12 | — | — | EP | disclosed |
| US-20130197257-A1 | NEW PROCESS | HOFFMANN-LA ROCHE INC. (US) | 2013-08-01 | — | — | US | disclosed |
| EP-2616433-A1 | NEW PROCESS | F.HOFFMANN-LA ROCHE AG (CH) | 2013-07-24 | — | — | EP | disclosed |
| EP-2094636-B1 | PROCESS FOR PREPARING 1-(2-ETHYL-BUTYL)-CYCLOHEXANECARBOXYLIC ACID | HOFFMANN LA ROCHE (CH) | 2012-10-24 | — | — | EP | disclosed |
| US-20090312569-A1 | NOVEL PROCESS | F. HOFFMANN-LA ROCHE AG (CH) | 2009-12-17 | — | — | US | disclosed |
| US-20090253927-A1 | PROCESS FOR CYCLOHEXANECARBOXYLIC ACID DERIVATIVES | HOFFMANN-LA ROCHE, INC. | 2009-10-08 | — | — | US | disclosed |
| WO-2009121788-A1 | NEW PROCESS FOR THE PREPARATIION OF CYCLOHEXANECARBOXYLIC ACID DERICATIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2009-10-08 | — | — | WO | disclosed |
| WO-2009121789-A1 | NEW PROCESS FOR THE PREPARATION OF CYCLOHEXANECARBOXYLIC ACID DERIVATIVES VIA THE CORRESPONDING CYCLOHEXANECARBOXAMIDE DERIVATIVE | F. HOFFMANN-LA ROCHE AG (CH) | 2009-10-08 | — | — | WO | disclosed |
| US-20090253928-A1 | PREPARATION FOR A CYCLOHEXANECARBOXYLIC ACID DERIVATIVE AND INTERMEDIATES | HOFFMANN-LA ROCHE, INC. | 2009-10-08 | — | — | US | disclosed |
| US-20090240080-A1 | PROCESS FOR THE PREPARATION OF CETP(1) | HOFFMANN URSULA | 2009-09-24 | — | — | US | disclosed |
| EP-2094636-A1 | PROCESS FOR PREPARING 1-(2-ETHYL-BUTYL)-CYCLOHEXANECARBOXYLIC ACID | F. Hoffmann-Roche AG (CH) | 2009-09-02 | — | — | EP | disclosed |
| US-20080154059-A1 | PROCESS FOR THE PREPARATION OF CETP(1) | HOFFMANN-LA ROCHE INC. | 2008-06-26 | — | — | US | disclosed |
| WO-2008074677-A1 | PROCESS FOR PREPARING 1- (2-ETHYL-BUTYL) -CYCLOHEXANECARBOXYLIC ACID | F. HOFFMANN-LA ROCHE AG (CH) | 2008-06-26 | — | — | WO | disclosed |
| EP-1935867-A1 | Process for preparing 1-(2-ethyl-butyl)-cyclohexanecarboxylic acid | F. HOFFMANN-LA ROCHE AG (CH) | 2008-06-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160200672-A1 | NEW PROCESS | CYP4A11, UGT1A1, CYP11B1 | CA1 3207/4885CA2 4156/4885CA9 849/4885 |
| US-20080154059-A1 | PROCESS FOR THE PREPARATION OF CETP(1) | CETP, CES1, CPA1 | CA1 2573/4885CA2 1923/4885CA9 1912/4885 |
| US-20150361034-A1 | NEW PROCESS | CYP4A11, UGT1A1, CYP11B1 | CA1 3207/4885CA2 4156/4885CA9 849/4885 |
| US-20090240080-A1 | PROCESS FOR THE PREPARATION OF CETP(1) | CETP, CES1, CPA1 | CA1 2573/4885CA2 1923/4885CA9 1912/4885 |
| US-20090253927-A1 | PROCESS FOR CYCLOHEXANECARBOXYLIC ACID DERIVATIVES | CYP2C9, CYP51A1, CYP2B6 | CA1 404/4885CA2 590/4885CA9 95/4885 |
| US-20090312569-A1 | NOVEL PROCESS | CYP3A5, MCCC2, CYP3A4 | CA1 1553/4885CA2 1216/4885CA9 510/4885 |
| US-20130197257-A1 | NEW PROCESS | CYP4A11, UGT1A1, CYP11B1 | CA1 3207/4885CA2 4156/4885CA9 849/4885 |
| US-20090253928-A1 | PREPARATION FOR A CYCLOHEXANECARBOXYLIC ACID DERIVATIVE AND INTERMEDIATES | CYP2A13, CYP1A1, CYP2C19 | CA1 431/4885CA2 934/4885CA9 175/4885 |
| US-20140336403-A1 | PROCESS | UGT1A1, CYP3A7, CYP2F1 | CA1 2253/4885CA2 3834/4885CA9 437/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.